Controlling Neuroinflammation In Alzheimer'S Disease

Abstract

Alzheimer’s disease (AD) is the most common neurodegenerative disorder worldwide, with 269,000 Australians currently diagnosed with AD and is expected to soar to about 981,000 by 2050. AD accounts for greater than 60% of all cases of dementia. This grant investigates the role that neuroinflammation plays in the progression and exacerbation of AD and will identify new therapeutic strategies to combat this insidious disease.

Related publications (1)

The contribution of astrocytes and microglia to traumatic brain injury

Ila P Karve, Juliet M Taylor, Peter J Crack

2016-02-01